Mortality in COPD patients discharged from hospital: The role of treatment and co-morbidity

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Gudmundsson, Gunnar ^a   Gislason, Thorarinn ^a   Lindberg, Eva ^b   Hallin, Runa ^b   Ulrik, Charlotte Suppli ^c   Brøndum, Eva ^c   Nieminen, Markku M ^d   Aine, Tiina ^d   Bakke, Per ^e   Janson, Christer ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; IPRATROPIUM BROMIDE; LONG ACTING DRUG; THEOPHYLLINE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DENMARK; DIABETES MELLITUS; DISEASE EXACERBATION; FEMALE; FINLAND; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ICELAND; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; OXYGEN THERAPY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SWEDEN; AGE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; EUROPE; INCIDENCE; MULTICENTER STUDY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL; SURVIVAL RATE; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PATIENT DISCHARGE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33748479470     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-109     Document Type: Article

References (31)

1. Hurd S: The impact of COPD on lung health worldwide: Epidemiology and incidence. Chest 2000, 117:1S-4S.
2. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effects of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
3. Anderson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prutz C, Ronmark E, Lundback B: The costs of exacerbations in chronic obstructive pulmonary disease. Resp Med 2002, 96:700-708.
4. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J: Mortality after hospitalization for COPD. Chest 2002, 121:1441-1448.
5. Connors AF, Dawson NV, Thomas C, Connors AF Jr, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA: Outcomes following acute exacerbation of severe chronic obstructive disease. Am J Respir Crit Care Med 1996, 154:959-967.
6. Groenewegen KH, AM Schols, Wouters EFM: Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003, 124:459-467.
7. Soriano JB, Vestbo J, Pride NB, Soriano JB, Kiri V, Maden C, Maier WC: Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Resp J 2002, 20:819-825.
8. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brondum E, Nieminen MM, Aine T, Bakke P: Depression, anxiety and health status after hospitalisation for COPD: A multi-centre study in the Nordic countries. Respir Med 2006, 100:87-93.
9. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brondum E, Nieminen MM, Aine T, Bakke P: Risk factors for rehospitalization in COPD: Health status, anxiety and depression. Eur Resp J 2005, 26:414-419.
10. Global initiative For Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. 2005 [http://www.goldcopd.org]. (Updated 2005)
11. European Community for Coal and Steel: Standardisation of lung function tests. Clin Respir Phys 1983, 19(Suppl 5):22-7.
12. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1991, 145:1321-7.
13. Jonas M, Reicher-Reiss H, Boyko V, Behar S, Grossman E: Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes and hypertension. J Hum Hypert 2003, 17:665-670.
14. Tedesco JV, Wright RS, Williams BA, Tedesco JV, Kopecky SL, Dvorak DL, Reeder GS, Miller WL, Mayo Coronary Care Unit Group: Effects of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proceedings 2003, 78:561-6.
15. Incalzi RA, Fuso L, DeRosa M: Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Resp J 1997, 10:2794-2800.
16. Yohannes AM, Baldwin RC, Connolly M: Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing 2002, 31:137-140.
17. Sin DD, Tu JV: Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:580-584.
18. Kiri VA, Bettoncelli G, Testi R, Viegi G: Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA. Resp Med 2005, 99:1115-1124.
19. Suissa S: Effectiveness of inhaled corticosteroids; in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168:49-53.
20. Suissa S: Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Resp J 2004, 23:391-395.
21. Fan VS, Bryson CL, Curtis RJ, Fihn SD, Bridevaux PO, McDonell MB, Au DH: Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Resp Crit Care Med 2003, 168:1488-1494.
22. TORCH study group: The TORCH (TOwards a Revolution in Copd Health) survival study protocol. Eur Resp J 2004, 24:206-210.
23. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD, Ambulatory Care Quality Improvement Project Investigators: Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002, 122:429-36.
24. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, et al.: Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Resp Crit Care Med 2003, 167:544-549.
25. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, Khalaf A, Marrades RM, Monso E, Serra-Batlles J, Anto JM: Health related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Resp Crit Gore Med 2002, 166:680-685.
26. Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL: Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Resp J 1996, 9:431-435.
27. Anthonisen NP, Wright EC, Hodgkin JE: Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986, 133:14-20.
28. Zielinski J, McNee W, Wedzicha JA, Ambrosino N, Braghiroli A, Dolensky J, Howard P, Gorzelak K, Lahdensuo A, Strom K, Tobiasz M, Weitzenblum E: Causes of death in patients with COPD and chronic respiratory failure. Mon Arch Chest Dis 1997, 52:43-47.
29. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population-based cohort study. Thorax 2006 in press. First: 31 May 2006. doi: 10.1136/ thx.2006.060145
30. Hansell AL, Walk JA, Soriano JB: What do chronic obstructive pulmonary disease patients die from. Eur Resp J 2003, 22:809-814.
31. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Menez RA, Plata VP, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-12.